Donald Trump’s pick to lead the federal health agency has vowed to replace hundreds of staffers and shift research away from infectious diseases and vaccines. Such an overhaul could imperil the ...

The Department of Government Efficiency (DOGE) said on Friday that a contract worth over $168,000 for the exhibit was ...

SAN DIEGO - Dare Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company focused on women's health, has been awarded a Notice of Award of a grant from the National Institute of Allergy and ...

The past three administrations have tried to limit gain-of-function research. The second Trump administration might be the ...

Early results from a trial testing a 2009 H1N1 influenza vaccine in children look promising, according to the trial sponsor, the National Institute of Allergy and Infectious Diseases (NIAID), part ...

Goodman also blamed "institutional inertia" and "circular reasoning" – that agencies had always experimented on animals – for not innovating outside animals, while Locke said feds were "passive and ...

Lactiga Inc. has been awarded a multiyear grant by the National Institute of Allergy and Infectious Diseases (NIAID) to accelerate the advancement of the company’s lead asset, LCTG-001.

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help ...

Dr. Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases (NIAID), told The Hill on Monday that he intends to accept the pardon preemptively offered to him by ...

Biden issued pardons for Fauci, the former director of the National Institute of Allergy and Infectious Diseases (NIAID) who led the nation’s COVID-19 pandemic response, and Milley, the former ...

The NIAID funding supplements a previous award of up to $10 million announced in October 2024 for supporting investigational new drug (IND) and Phase 2 clinical study activities. DARE-HPV is an ...